Skip to main content

Advertisement

ADVERTISEMENT

Videos

Headshot of Jeffrey Stark on a blue background underneath the PopHealth Perspectives logo.
Videos
07/26/2021
Jeffrey Stark, MD, head of immunology medical affairs, UCB, breaks down the unique challenges patients with psoriasis face, and discusses the BE RADIANT and BE SURE studies, both of which indicated that bimekizumab was effective at achieving...
Jeffrey Stark, MD, head of immunology medical affairs, UCB, breaks down the unique challenges patients with psoriasis face, and discusses the BE RADIANT and BE SURE studies, both of which indicated that bimekizumab was effective at achieving...
Jeffrey Stark, MD, head of...
07/26/2021
First Report Managed Care

Advertisement

Headshot of Dr Efstathios Kastritis on a blue background underneath the PopHealth Perspectives logo.
Videos
07/12/2021
Efstathios Kastritis, MD, associate professor of clinical therapeutics/medical oncology, National and Kapodistrian University of Athens, School of Medicine, discusses the findings of the ANDROMEDA study, a phase 3 clinical study that...
Efstathios Kastritis, MD, associate professor of clinical therapeutics/medical oncology, National and Kapodistrian University of Athens, School of Medicine, discusses the findings of the ANDROMEDA study, a phase 3 clinical study that...
Efstathios Kastritis, MD,...
07/12/2021
Population Health
First-Line Treatment Approaches for Metastatic Urothelial Cancer in the US
Videos
05/04/2021
Petros Grivas, MD, PhD, discusses results from a study exploring decision-making processes regarding first-line treatment choices, testing practices and treatment eligibility determinants for patients with metastatic urothelial cancer.
Petros Grivas, MD, PhD, discusses results from a study exploring decision-making processes regarding first-line treatment choices, testing practices and treatment eligibility determinants for patients with metastatic urothelial cancer.
Petros Grivas, MD, PhD,...
05/04/2021
Journal of Clinical Pathways
Expanded FDA Approval Improves Care Access, Rates of Flu Cases
Videos
04/19/2021
Gregg Sylvester, MD, MPH, chief medical officer, and David Ross, vice president, commercial operations for North America, both at Seqirus, discuss the recent FDA approval for Flucelvax Quadrivalent, explain what the expanded indication means...
Gregg Sylvester, MD, MPH, chief medical officer, and David Ross, vice president, commercial operations for North America, both at Seqirus, discuss the recent FDA approval for Flucelvax Quadrivalent, explain what the expanded indication means...
Gregg Sylvester, MD, MPH, chief...
04/19/2021
Pharmacy Learning Network

Advertisement

Real-World Survival Trends in Muscle-Invasive Bladder Cancer and Urothelial Carcinoma
Videos
03/12/2021
Nimira Alimohamed, MD, discusses results from a real-world analysis of outcomes over time in patients with muscle-invasive bladder cancer and patients with metastatic urothelial carcinoma.
Nimira Alimohamed, MD, discusses results from a real-world analysis of outcomes over time in patients with muscle-invasive bladder cancer and patients with metastatic urothelial carcinoma.
Nimira Alimohamed, MD, discusses...
03/12/2021
Journal of Clinical Pathways
Study Finds No Correlation Between Antibiotic Use and OS in Metastatic Urothelial Carcinoma
Videos
02/19/2021
Shilpa Gupta, MD, discusses the effect of antibiotic use within 30 days of initiation of immune checkpoint inhibitors on overall survival among patients with metastatic urothelial carcinoma in real-world practice.
Shilpa Gupta, MD, discusses the effect of antibiotic use within 30 days of initiation of immune checkpoint inhibitors on overall survival among patients with metastatic urothelial carcinoma in real-world practice.
Shilpa Gupta, MD, discusses the...
02/19/2021
Journal of Clinical Pathways
Beneficial Treatments for OFF Episodes Among Patients With PD
Videos
02/18/2021
Maria C Ospina, MD, movement disorder neurologist, discusses how physicians can ensure they receive all of the information needed to unlock patterns of Parkinson disease among their patients, and breaks down treatment options for OFF episodes...
Maria C Ospina, MD, movement disorder neurologist, discusses how physicians can ensure they receive all of the information needed to unlock patterns of Parkinson disease among their patients, and breaks down treatment options for OFF episodes...
Maria C Ospina, MD, movement...
02/18/2021
Annals of Long-Term Care

Advertisement

Utilizing Scheduling Technology to Improve Patient Engagement, Manage Vaccine Administration
Videos
02/05/2021
Danny Sanchez, vice president and general manager, EnlivenHealth, speaks about the benefits of the CareScheduler tool; outlines how it improves processes for pharmacists, health plans, and patients; as well as highlights how this kind of...
Danny Sanchez, vice president and general manager, EnlivenHealth, speaks about the benefits of the CareScheduler tool; outlines how it improves processes for pharmacists, health plans, and patients; as well as highlights how this kind of...
Danny Sanchez, vice president...
02/05/2021
First Report Managed Care
Beneficial PTSD Initiatives and How to Better Help Veteran Patients Become More Aware of Resources
Videos
01/08/2021
Ryan Rogers, MBA, DHS candidate, director of business management, PTSD Foundation of America, discusses the Foundation and its initiatives, including Camp Hope, how clinicians can help veterans with PTSD become more aware of various...
Ryan Rogers, MBA, DHS candidate, director of business management, PTSD Foundation of America, discusses the Foundation and its initiatives, including Camp Hope, how clinicians can help veterans with PTSD become more aware of various...
Ryan Rogers, MBA, DHS candidate,...
01/08/2021
Veterans Health Today
Identifying Drug Diversion Differences in Retail Pharmacies Compared With Health Systems
Videos
12/28/2020
Tom Knight, founder and CEO, Invistics, identifies drug diversion differences in a hospital or health system versus a retail pharmacy, and explains what retail pharmacies can do to better detect and address drug diversion.
Tom Knight, founder and CEO, Invistics, identifies drug diversion differences in a hospital or health system versus a retail pharmacy, and explains what retail pharmacies can do to better detect and address drug diversion.
Tom Knight, founder and CEO,...
12/28/2020
Pharmacy Learning Network

Advertisement

Advertisement